Precision medicine in newly diagnosed breast cancer

Implementing precision medicine in oncology: The IMPACT trials

Lessons from long-term survey of stage I NSCLC

Editor's Choice for June 2018

Improved OS with obinutuzumab in the CLL11 study

Editor’s Choice for May 2018

The evolution of imaging techniques for multiple myeloma

Diagnosis and management of smouldering myeloma

Phase I taselisib results and a cell-free DNA assay

Impact of microbiome on head and neck cancers

First-in-human trial results of RET targeted BLU-667

Treating RET alterations with novel therapy BLU-667